2 Dow 30 Stocks Enjoying the Bounce

Pfizer Inc. (NYSE:PFE) reported that its marketing authorization for axitinib in the European Union has received a positive opinion from the Committee for Human Medicinal Products of the European Medicines Agency. The drug is aimed at the treatment of adult patients having advanced renal cell carcinoma, which is a type of advanced kidney cancer, subsequent to failure of prior treatment with sunitinib or a cytokine. The European Commission, which possesses the authority to approve medicines for the European Union, will evaluate the Committee’s positive opinion on axitinib, and Pfizer expects a decision withing the coming months on the matter.

Don’t Miss: Steve Blank: Facebook is Ruining Silicon Valley.

Verizon Communications Inc.’s (NYSE:VZ) (NASDAQ:VOD) plans to purchase valuable wireless spectrum from a group of domestic cable TV companies, is the subject of a possible inquiry by Senator Herb Kohl, the chairman of the Senate Antitrust Subcommittee, according to a Financial Times report. Kohl thinks that the transactions could represent important competition issues. The cable companies include Comcast (NASDAQ:CMCSA) and Time Warner Cable (NYSE:TWC).

Earnings Report: VeriFone Systems Earnings: Here’s Why Shares Are Falling.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.